메뉴 건너뛰기




Volumn 80, Issue 11, 2008, Pages 4133-4140

Terbutaline enantiomer separation and quantification by complexation and field asymmetric ion mobility spectrometry-tandem mass spectrometry

Author keywords

[No Author keywords available]

Indexed keywords

AMINATION; AMINES; AMINO ACIDS; CHARGED PARTICLES; CHEMICAL MODIFICATION; CHEMOTHERAPY; CHIRALITY; DRUG DELIVERY; DRUG DOSAGE; DRUG THERAPY; ELECTRONS; ENANTIOMERS; HEALTH; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMERS; MASS SPECTROMETERS; MASS SPECTROMETRY; METAL ANALYSIS; METAL IONS; ORGANIC ACIDS; SEPARATION; SPECTROMETERS; SPECTROMETRY; SPECTRUM ANALYSIS; TELLURIUM COMPOUNDS;

EID: 44949240697     PISSN: 00032700     EISSN: None     Source Type: Journal    
DOI: 10.1021/ac702262k     Document Type: Article
Times cited : (41)

References (43)
  • 3
    • 44949191703 scopus 로고    scopus 로고
    • Anonymous Guidance for Industry: Q3A(R2) Impurities in New Drug Substances. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), 2006.
    • Anonymous Guidance for Industry: Q3A(R2) Impurities in New Drug Substances. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), 2006.
  • 4
    • 44949156696 scopus 로고    scopus 로고
    • Anonymous Guidance for Industry: Q6A Specifications: test procedures and acceptance criteria for new drug substances and new drug products. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). 1999.
    • Anonymous Guidance for Industry: Q6A Specifications: test procedures and acceptance criteria for new drug substances and new drug products. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). 1999.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.